Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Eiger Biopharma
(NQ:
EIGR
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Apr 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Eiger Biopharma
< Previous
1
2
3
4
5
Next >
Why Is Sigma Lithium (SGML) Stock Up 14% Today?
September 13, 2023
Sigma Lithium (SGML) stock is climbing higher on Wednesday after confirming it has received multiple strategic proposals.
Via
InvestorPlace
Nasdaq Gains 50 Points; US Inflation Rate Rises In August
September 13, 2023
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 50 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.11% to 34,685.47 while the NASDAQ...
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
WKHS Stock Alert: The $40,000 Reason Workhorse Is Up Today
September 13, 2023
Workhorse (WKHS) stock is on the rise Wednesday thanks to a new update from the IRS concerning its electric vehicle (EV) manufacturer status.
Via
InvestorPlace
Topics
Electric Vehicles
Exposures
Electric Vehicles
Why Is Eiger BioPharmaceuticals (EIGR) Stock Down 31% Today?
September 13, 2023
Eiger BioPharmaceuticals (EIGR) stock is falling on Wednesday after the biopharmaceutical company halted a Phase 3 clinical trial.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
September 13, 2023
Via
Benzinga
Recap: Eiger BioPharmaceuticals Q1 Earnings
May 11, 2023
Via
Benzinga
Eiger BioPharmaceuticals Earnings Perspective: Return On Capital Employed
March 20, 2023
Via
Benzinga
Why Is Hepatitis Player Eiger BioPharma Stock Trading Lower Today?
September 13, 2023
Eiger BioPharmaceuticals Inc (NASDAQ: EIGR) has discontinued the Phase 3 LIMT-2 study of peginterferon lambda in patients with
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
September 13, 2023
It's time for another dive into the biggest pre-market stock movers as we check out all the shares worth watching on Wednesday!
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
September 12, 2023
Via
Benzinga
Potential Upside For Eiger's Avexitide In Both PBH And CHI Indications: Analyst
June 30, 2023
Thursday, Eiger BioPharmaceuticals Inc (NASDAQ: EIGR) announced it would focus its development efforts on advancing avexitide in
Via
Benzinga
Why Cineverse Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Friday's Mid-Day Session
June 30, 2023
Gainers Addentax Group Corp. (NASDAQ: ATXG) shares jumped 47.3% to $9.68. Addentax Group is launching automation of artificial intelligence internet operational tools project with top...
Via
Benzinga
Eiger BioPharmaceuticals Makes Interim CEO Permanent, It Chalks Out Portfolio Prioritization Review, Layoffs
June 29, 2023
Eiger BioPharmaceuticals Inc (NASDAQ: EIGR) announced it would focus its development efforts on advancing avexitide in
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
March 16, 2023
Via
Benzinga
Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank
March 11, 2023
The collapse of SVB Financial Group (NASDAQ: SIVB) could have a ripple effect on the technology and biotech industries, the two largest sectors that had deposits and financial relationships with the...
Via
Benzinga
Eiger BioPharma's Single Dose Of Peginterferon Lambda Cuts Risk Of COVID-19-Related Hospitalizations, Deaths
February 09, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
February 09, 2023
Via
Benzinga
Eiger BioPharmaceuticals And 2 Other Penny Stocks Insiders Are Aggressively Buying
January 26, 2023
The Dow Jones closed slightly higher on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in...
Via
Benzinga
Why Tivic Health Systems Are Trading Lower By 55%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
February 09, 2023
Gainers Hempacco Co., Inc. (NASDAQ: HPCO) rose 296% to $2.99 after declining 6% on Wednesday.
Via
Benzinga
Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) Long Term Investor Alert: Investigation of Potential Wrongdoing
January 20, 2023
San Diego, CA -- (SBWIRE) -- 01/20/2023 -- An investigation was announced long-term investors in shares of Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) concerning potential breaches of fiduciary duties...
Via
SBWire
Deadline Alert: Bronstein, Gewirtz & Grossman, LLC, A Successful Firm, Notifies Eiger BioPharmaceuticals, Inc. (EIGR) Investors of Class Action and Encourages Investors to Actively Participate
January 09, 2023
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
EIGER DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Eiger Biopharmaceuticals, Inc. and Encourages Investors to Contact the Firm
January 06, 2023
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Eiger BioPharmaceuticals, Inc. (EIGR)
January 06, 2023
From
Law Offices of Frank R. Cruz
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 04, 2023
Via
Benzinga
EIGR FINAL DEADLINE ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Eiger BioPharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important January 9 Deadline in Securities Class Action - EIGR
January 04, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vintage Wine, Eiger, Unisys, and Rent and Encourages Investors to Contact the Firm
January 03, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
Looking Into Eiger BioPharmaceuticals's Recent Short Interest
January 03, 2023
Eiger BioPharmaceuticals's (NASDAQ:EIGR) short percent of float has risen 8.06% since its last report. The company recently reported that it has 1.57 million shares sold short, which is 4.29% of all...
Via
Benzinga
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Eiger BioPharmaceuticals, Inc. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action - EIGR
December 29, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
EIGER ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Eiger Biopharmaceuticals, Inc. and Encourages Investors to Contact the Firm
December 28, 2022
From
Bragar Eagel & Squire
Via
GlobeNewswire
ROSEN, A TOP RANKED LAW FIRM, Encourages Eiger BioPharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EIGR
December 25, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.